Abstract
Colorectal cancer (CRC) is a genetically diverse disease necessitating the need for well-characterized and reproducible models to enable its accurate investigation. Recent genomic analyses have confirmed that CRC cell lines accurately retain the key genetic alterations and represent the major molecular subtypes of primary CRC, underscoring their value as powerful preclinical models. In this chapter we detail the important issues to consider when using CRC cell lines, the techniques used for their appropriate molecular classification, and the methods by which they are cultured in vitro and as subcutaneous xenografts in immune-compromised mice. A panel of commonly available CRC cell lines that have been characterized for key molecular subtypes is also provided as a resource for investigators to select appropriate models to address specific research questions.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Shibata D, Peinado MA, lonov Y et al (1994) Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation. Nat Genet 6(3):273–281
Lengauer C, Kinzler KW, Vogelstein B (1997) Genetic instability in colorectal cancers. Nature 386(6625):623–627
Issa J-P (2004) CpG island methylator phenotype in cancer. Nat Rev Cancer 4(12):988–993
Bellam N, Pasche B (2010) TGF-β signaling alterations and colon cancer. In: Pasche B (ed) Cancer genetics. Springer, Boston, MA, pp 85–103. https://doi.org/10.1007/978-1-4419-6033-7_5
Cathomas G (2014) PIK3CA in colorectal cancer. Front Oncol 4:35. https://doi.org/10.3389/fonc.2014.00035
Colussi D, Brandi G, Bazzoli F et al (2013) Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention. Int J Mol Sci 14(8):16365–16385. https://doi.org/10.3390/ijms140816365
Barras D (2015) BRAF mutation in colorectal cancer: an update. Biomark Cancer 7(Suppl 1):9–12. https://doi.org/10.4137/bic.s25248
Morkel M, Riemer P, Bläker H et al (2015) Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance. Oncotarget 6(25):20785–20800
Guinney J, Dienstmann R, Wang X et al (2015) The consensus molecular subtypes of colorectal cancer. Nat Med 21(11):1350–1356. https://doi.org/10.1038/nm.3967
Young L, Sung J, Stacey G et al (2010) Detection of mycoplasma in cell cultures. Nat Protoc 5(5):929–934
Tögel L, Nightingale R, Chueh AC et al (2016) Dual targeting of bromodomain and extraterminal domain proteins, and WNT or MAPK signaling, inhibits c-MYC expression and proliferation of colorectal cancer cells. Mol Cancer Ther 15(6):1217
Shin J, Carr A, Corner GA et al (2014) The intestinal epithelial cell differentiation marker intestinal alkaline phosphatase (ALPi) is selectively induced by histone deacetylase inhibitors (HDACi) in colon cancer cells in a kruppel-like factor 5 (KLF5)-dependent manner. J Biol Chem 289(36):25306–25316. https://doi.org/10.1074/jbc.M114.557546
Wilson AJ, Chueh AC, Tögel L et al (2010) A coordinated Sp1/Sp3-mediated transcriptional response involving immediate-early gene induction is linked to HDAC inhibitor-induced apoptosis in colon cancer cells. Cancer Res 70(2):609–620. https://doi.org/10.1158/0008-5472.CAN-09-2327
Butler JM (2007) Short tandem repeat ty** technologies used in human identity testing. BioTechniques 43(4):ii–iv
Nikfarjam L, Farzaneh P (2012) Prevention and detection of mycoplasma contamination in cell culture. Cell J 13(4):203–212
Bacher JW, Flanagan LA, Smalley RL et al (2004) Development of a fluorescent multiplex assay for detection of MSI-high tumors. Dis Markers 20(4–5):237–250
Eads CA, Danenberg KD, Kawakami K et al (2000) MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 28(8):E32
Weisenberger DJ, Campan M, Long TI et al (2005) Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res 33(21):6823–6836. https://doi.org/10.1093/nar/gki987
Gu H, Bock C, Mikkelsen TS et al (2010) Genome-scale DNA methylation map** of clinical samples at single-nucleotide resolution. Nat Methods 7(2):133–136. https://doi.org/10.1038/nmeth.1414
Wojdacz TK, Dobrovic A (2007) Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation. Nucleic Acids Res 35(6):e41. https://doi.org/10.1093/nar/gkm013
Jasmine F, Rahaman R, Roy S et al (2012) Interpretation of genome-wide infinium methylation data from ligated DNA in formalin-fixed, paraffin-embedded paired tumor and normal tissue. BMC Res Notes 5:117. https://doi.org/10.1186/1756-0500-5-117
Weisenberger DJ, Siegmund KD, Campan M et al (2006) CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 38(7):787–793. https://doi.org/10.1038/ng1834
Nosho K, Irahara N, Shima K et al (2008) Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample. PLoS One 3(11):e3698. https://doi.org/10.1371/journal.pone.0003698
Ogino S, Kawasaki T, Brahmandam M et al (2006) Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. J Mol Diagn 8(2):209–217. https://doi.org/10.2353/jmoldx.2006.050135
Lindor NM, Burgart LJ, Leontovich O et al (2002) Immunohistochemistry versus microsatellite instability testing in phenoty** colorectal tumors. J Clin Oncol 20(4):1043–1048. https://doi.org/10.1200/JCO.2002.20.4.1043
Shi C, Washington K (2012) Molecular testing in colorectal cancer: diagnosis of lynch syndrome and personalized cancer medicine. Am J Clin Pathol 137(6):847–859. https://doi.org/10.1309/AJCPI83DINULUJNI
Berg KD, Glaser CL, Thompson RE et al (2000) Detection of microsatellite instability by fluorescence multiplex polymerase chain reaction. J Mol Diagn 2(1):20–28
Murphy KM, Zhang S, Geiger T et al (2006) Comparison of the microsatellite instability analysis system and the Bethesda panel for the determination of microsatellite instability in colorectal cancers. J Mol Diagn 8(3):305–311. https://doi.org/10.2353/jmoldx.2006.050092
Sah S, Chen L, Houghton J et al (2013) Functional DNA quantification guides accurate next-generation sequencing mutation detection in formalin-fixed, paraffin-embedded tumor biopsies. Genome Med 5(8):77. https://doi.org/10.1186/gm481
Simbolo M, Gottardi M, Corbo V et al (2013) DNA qualification workflow for next generation sequencing of histopathological samples. PLoS One 8(6):e62692. https://doi.org/10.1371/journal.pone.0062692
Ogino S, Kawasaki T, Kirkner GJ et al (2007) Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample. J Mol Diagn 9(3):305–314. https://doi.org/10.2353/jmoldx.2007.060170
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Appendix 1
Appendix 1
Reference STR profiles and properties of 30 commonly used CRC cell lines
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Mooi, J.K., Luk, I.Y., Mariadason, J.M. (2018). Cell Line Models of Molecular Subtypes of Colorectal Cancer. In: Beaulieu, JF. (eds) Colorectal Cancer. Methods in Molecular Biology, vol 1765. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7765-9_1
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7765-9_1
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7764-2
Online ISBN: 978-1-4939-7765-9
eBook Packages: Springer Protocols